Loading…

Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)

Background A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D). The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes and metabolic disorders 2017-01, Vol.16 (1), p.5-5, Article 5
Main Authors: Mays, Christopher A., Hunter, Daniel A., Yau, Wilson, Gato, Worlanyo E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33
cites cdi_FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33
container_end_page 5
container_issue 1
container_start_page 5
container_title Journal of diabetes and metabolic disorders
container_volume 16
creator Mays, Christopher A.
Hunter, Daniel A.
Yau, Wilson
Gato, Worlanyo E.
description Background A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D). The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA). T1D is an autoimmune disease of the pancreatic islet in which insulin-producing beta cells are destroyed by auto-reactive T-cells and monocytic cells. Methods The purpose of this study is to examine the extent to which 2AA exposure contributes to T1D. Three groups of pregnant Sprague Dawley dams ingested various concentrations of dietary 2AA from gestation through the postnatal period. A select number of cytokines and adipokines previously noted to play a significant role in inflammatory response were analyzed in the pancreas of the pups for alteration. The anatomy of the pancreas was also evaluated to determine any histological changes. Results Results showed over-expression of pro-inflammatory protein IL-6. Up-regulation of humoral genes IL-7 and IL-21 were also noted. Pathologic characterization showed no significant changes. Moreover, serum total protein was significantly reduced in exposed groups. Elevated serum glucose concentration seems to correspond to slightly lower insulin levels in serum. Cumulative neonatal weight gain analysis showed no major alterations between the control and gestationally-exposed rats. Conclusion It appears that systemic effects of 2AA ingestion were mild in the neonates. Further assessments of pups who lived longer than two weeks could be a useful way to measure the progression and possibly further support our hypothesis that 2AA can lead to systemic effects that are indicative of inducing T1D.
doi_str_mv 10.1186/s40200-017-0286-6
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5273839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A479151508</galeid><sourcerecordid>A479151508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhgdRbKn9AW4kIMjtYjTfk9kIQ60fUHBT1yGTObkzdW5yTTJq_31zmVqugtkkcJ7zcE7eqnpJ8FtClHyXOKYY15g0NaZK1vJJdUqpILUUijw9ep9U5ynd4nKaRikin1cnVBHeKsZOK-hSgpR24DMKDuUR0Dz576iH_AvAo8mjJUMMCH7vQ1oioBwQrc1u8sH4PEZjwQPa0K67QMYPKN_toSZomExRQEKbG_Lh4kX1zJk5wfnDfVZ9-3h1c_m5vv766ctld11bgUmuHW7c4Hope2tNL0zPieK2bZwxnBrgjnHmsDWqF9Aq2QzWScbJoCxue2oYO6ver9790u9gKKPlaGa9j9POxDsdzKT_rvhp1NvwUwvaMMXaItg8CGL4sUDKejclC_NsPIQl6fLxQlAqMS7o63_Q27BEX9Y7ULxtCeMH4ZuV2poZ9AhmzmMK85Kn4JPueNMSQQRWBSQraGNIKYJ7nJpgfQhcr4HrErg-BK5l6Xl1vO5jx594C0BXIJWS30I8mvG_1nvym7UB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1864991349</pqid></control><display><type>article</type><title>Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)</title><source>PubMed Central (Open Access)</source><source>Springer Link</source><creator>Mays, Christopher A. ; Hunter, Daniel A. ; Yau, Wilson ; Gato, Worlanyo E.</creator><creatorcontrib>Mays, Christopher A. ; Hunter, Daniel A. ; Yau, Wilson ; Gato, Worlanyo E.</creatorcontrib><description>Background A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D). The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA). T1D is an autoimmune disease of the pancreatic islet in which insulin-producing beta cells are destroyed by auto-reactive T-cells and monocytic cells. Methods The purpose of this study is to examine the extent to which 2AA exposure contributes to T1D. Three groups of pregnant Sprague Dawley dams ingested various concentrations of dietary 2AA from gestation through the postnatal period. A select number of cytokines and adipokines previously noted to play a significant role in inflammatory response were analyzed in the pancreas of the pups for alteration. The anatomy of the pancreas was also evaluated to determine any histological changes. Results Results showed over-expression of pro-inflammatory protein IL-6. Up-regulation of humoral genes IL-7 and IL-21 were also noted. Pathologic characterization showed no significant changes. Moreover, serum total protein was significantly reduced in exposed groups. Elevated serum glucose concentration seems to correspond to slightly lower insulin levels in serum. Cumulative neonatal weight gain analysis showed no major alterations between the control and gestationally-exposed rats. Conclusion It appears that systemic effects of 2AA ingestion were mild in the neonates. Further assessments of pups who lived longer than two weeks could be a useful way to measure the progression and possibly further support our hypothesis that 2AA can lead to systemic effects that are indicative of inducing T1D.</description><identifier>ISSN: 2251-6581</identifier><identifier>EISSN: 2251-6581</identifier><identifier>DOI: 10.1186/s40200-017-0286-6</identifier><identifier>PMID: 28149833</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Care and treatment ; Diabetes ; Diagnosis ; Endocrinology ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Monocytes ; Research Article ; T cells ; Type 1 diabetes</subject><ispartof>Journal of diabetes and metabolic disorders, 2017-01, Vol.16 (1), p.5-5, Article 5</ispartof><rights>The Author(s). 2017</rights><rights>COPYRIGHT 2017 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33</citedby><cites>FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33</cites><orcidid>0000-0002-4781-8577</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273839/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273839/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28149833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mays, Christopher A.</creatorcontrib><creatorcontrib>Hunter, Daniel A.</creatorcontrib><creatorcontrib>Yau, Wilson</creatorcontrib><creatorcontrib>Gato, Worlanyo E.</creatorcontrib><title>Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)</title><title>Journal of diabetes and metabolic disorders</title><addtitle>J Diabetes Metab Disord</addtitle><addtitle>J Diabetes Metab Disord</addtitle><description>Background A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D). The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA). T1D is an autoimmune disease of the pancreatic islet in which insulin-producing beta cells are destroyed by auto-reactive T-cells and monocytic cells. Methods The purpose of this study is to examine the extent to which 2AA exposure contributes to T1D. Three groups of pregnant Sprague Dawley dams ingested various concentrations of dietary 2AA from gestation through the postnatal period. A select number of cytokines and adipokines previously noted to play a significant role in inflammatory response were analyzed in the pancreas of the pups for alteration. The anatomy of the pancreas was also evaluated to determine any histological changes. Results Results showed over-expression of pro-inflammatory protein IL-6. Up-regulation of humoral genes IL-7 and IL-21 were also noted. Pathologic characterization showed no significant changes. Moreover, serum total protein was significantly reduced in exposed groups. Elevated serum glucose concentration seems to correspond to slightly lower insulin levels in serum. Cumulative neonatal weight gain analysis showed no major alterations between the control and gestationally-exposed rats. Conclusion It appears that systemic effects of 2AA ingestion were mild in the neonates. Further assessments of pups who lived longer than two weeks could be a useful way to measure the progression and possibly further support our hypothesis that 2AA can lead to systemic effects that are indicative of inducing T1D.</description><subject>Care and treatment</subject><subject>Diabetes</subject><subject>Diagnosis</subject><subject>Endocrinology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Monocytes</subject><subject>Research Article</subject><subject>T cells</subject><subject>Type 1 diabetes</subject><issn>2251-6581</issn><issn>2251-6581</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kU1rFTEUhgdRbKn9AW4kIMjtYjTfk9kIQ60fUHBT1yGTObkzdW5yTTJq_31zmVqugtkkcJ7zcE7eqnpJ8FtClHyXOKYY15g0NaZK1vJJdUqpILUUijw9ep9U5ynd4nKaRikin1cnVBHeKsZOK-hSgpR24DMKDuUR0Dz576iH_AvAo8mjJUMMCH7vQ1oioBwQrc1u8sH4PEZjwQPa0K67QMYPKN_toSZomExRQEKbG_Lh4kX1zJk5wfnDfVZ9-3h1c_m5vv766ctld11bgUmuHW7c4Hope2tNL0zPieK2bZwxnBrgjnHmsDWqF9Aq2QzWScbJoCxue2oYO6ver9790u9gKKPlaGa9j9POxDsdzKT_rvhp1NvwUwvaMMXaItg8CGL4sUDKejclC_NsPIQl6fLxQlAqMS7o63_Q27BEX9Y7ULxtCeMH4ZuV2poZ9AhmzmMK85Kn4JPueNMSQQRWBSQraGNIKYJ7nJpgfQhcr4HrErg-BK5l6Xl1vO5jx594C0BXIJWS30I8mvG_1nvym7UB</recordid><startdate>20170128</startdate><enddate>20170128</enddate><creator>Mays, Christopher A.</creator><creator>Hunter, Daniel A.</creator><creator>Yau, Wilson</creator><creator>Gato, Worlanyo E.</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4781-8577</orcidid></search><sort><creationdate>20170128</creationdate><title>Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)</title><author>Mays, Christopher A. ; Hunter, Daniel A. ; Yau, Wilson ; Gato, Worlanyo E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Care and treatment</topic><topic>Diabetes</topic><topic>Diagnosis</topic><topic>Endocrinology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Monocytes</topic><topic>Research Article</topic><topic>T cells</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mays, Christopher A.</creatorcontrib><creatorcontrib>Hunter, Daniel A.</creatorcontrib><creatorcontrib>Yau, Wilson</creatorcontrib><creatorcontrib>Gato, Worlanyo E.</creatorcontrib><collection>Springer Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes and metabolic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mays, Christopher A.</au><au>Hunter, Daniel A.</au><au>Yau, Wilson</au><au>Gato, Worlanyo E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)</atitle><jtitle>Journal of diabetes and metabolic disorders</jtitle><stitle>J Diabetes Metab Disord</stitle><addtitle>J Diabetes Metab Disord</addtitle><date>2017-01-28</date><risdate>2017</risdate><volume>16</volume><issue>1</issue><spage>5</spage><epage>5</epage><pages>5-5</pages><artnum>5</artnum><issn>2251-6581</issn><eissn>2251-6581</eissn><abstract>Background A recent diabetes report revealed an increased incidence in diabetes including type 1-diabetes (T1D). The increase in the numbers of T1D incidences are thought to be related to environmental reasons such as the exposure to environmental chemicals including arylamine 2-aminoanthracene (2AA). T1D is an autoimmune disease of the pancreatic islet in which insulin-producing beta cells are destroyed by auto-reactive T-cells and monocytic cells. Methods The purpose of this study is to examine the extent to which 2AA exposure contributes to T1D. Three groups of pregnant Sprague Dawley dams ingested various concentrations of dietary 2AA from gestation through the postnatal period. A select number of cytokines and adipokines previously noted to play a significant role in inflammatory response were analyzed in the pancreas of the pups for alteration. The anatomy of the pancreas was also evaluated to determine any histological changes. Results Results showed over-expression of pro-inflammatory protein IL-6. Up-regulation of humoral genes IL-7 and IL-21 were also noted. Pathologic characterization showed no significant changes. Moreover, serum total protein was significantly reduced in exposed groups. Elevated serum glucose concentration seems to correspond to slightly lower insulin levels in serum. Cumulative neonatal weight gain analysis showed no major alterations between the control and gestationally-exposed rats. Conclusion It appears that systemic effects of 2AA ingestion were mild in the neonates. Further assessments of pups who lived longer than two weeks could be a useful way to measure the progression and possibly further support our hypothesis that 2AA can lead to systemic effects that are indicative of inducing T1D.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>28149833</pmid><doi>10.1186/s40200-017-0286-6</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4781-8577</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2251-6581
ispartof Journal of diabetes and metabolic disorders, 2017-01, Vol.16 (1), p.5-5, Article 5
issn 2251-6581
2251-6581
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5273839
source PubMed Central (Open Access); Springer Link
subjects Care and treatment
Diabetes
Diagnosis
Endocrinology
Medicine
Medicine & Public Health
Metabolic Diseases
Monocytes
Research Article
T cells
Type 1 diabetes
title Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A48%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20link%20between%20in%20utero%20exposure%20to%202-aminoanthracene%20(2AA)%20and%20type-1%20diabetes%20(T1D)&rft.jtitle=Journal%20of%20diabetes%20and%20metabolic%20disorders&rft.au=Mays,%20Christopher%20A.&rft.date=2017-01-28&rft.volume=16&rft.issue=1&rft.spage=5&rft.epage=5&rft.pages=5-5&rft.artnum=5&rft.issn=2251-6581&rft.eissn=2251-6581&rft_id=info:doi/10.1186/s40200-017-0286-6&rft_dat=%3Cgale_pubme%3EA479151508%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c501t-f07fdfb66bccab5ab4184c97faa42ae4f343f0ca8b5e9867dcf6341d8c09b2a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1864991349&rft_id=info:pmid/28149833&rft_galeid=A479151508&rfr_iscdi=true